A detailed history of Eversept Partners, LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 336,966 shares of MRVI stock, worth $1.8 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
336,966
Holding current value
$1.8 Million
% of portfolio
0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $2.3 Million - $3.28 Million
336,966 New
336,966 $2.8 Million
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $4.13 Million - $5.81 Million
452,323 New
452,323 $4.52 Million
Q3 2022

Nov 08, 2023

SELL
$20.6 - $30.37 $5.47 Million - $8.06 Million
-265,364 Reduced 62.39%
160,000 $4.08 Million
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $5.47 Million - $8.06 Million
-265,364 Reduced 62.39%
160,000 $4.09 Million
Q2 2022

Nov 08, 2023

BUY
$26.05 - $37.48 $11.1 Million - $15.9 Million
425,364 New
425,364 $12.1 Million
Q2 2022

Aug 15, 2022

BUY
$26.05 - $37.48 $11.1 Million - $15.9 Million
425,364 New
425,364 $12.1 Million
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $2.15 Million - $3.59 Million
-87,795 Closed
0 $0
Q4 2021

Nov 08, 2023

SELL
$35.0 - $45.94 $8.4 Million - $11 Million
-240,015 Reduced 73.22%
87,795 $3.68 Million
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $8.4 Million - $11 Million
-240,015 Reduced 73.22%
87,795 $3.68 Million
Q3 2021

Nov 08, 2023

BUY
$36.8 - $60.62 $9.3 Million - $15.3 Million
252,810 Added 337.08%
327,810 $16.1 Million
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $9.3 Million - $15.3 Million
252,810 Added 337.08%
327,810 $16.1 Million
Q2 2021

Nov 08, 2023

BUY
$32.46 - $45.0 $2.43 Million - $3.38 Million
75,000 New
75,000 $3.13 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $45.0 $2.43 Million - $3.38 Million
75,000 New
75,000 $3.13 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $701M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.